The Pennant Group, Inc. is a medical - care facilities company in the healthcare sector trading on NASDAQ, led by CEO Brent J. Guerisoli, with a market cap of $1.2B.
Upcoming earnings announcement for The Pennant Group, Inc.
Past 12 earnings reports for The Pennant Group, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | $0.34Est: $0.29 | +17.2% | $289.3MEst: $274.3M | +5.5% | |
| Nov 5, 2025 | Q3 2025 | $0.30Est: $0.26 | +15.4% | $229.0MEst: $222.5M | +3.0% | |
| Aug 6, 2025 | Q2 2025 | $0.27Est: $0.25 | +8.0% | $219.5MEst: $211.5M | +3.8% | |
| May 6, 2025 | Q1 2025 | $0.27Est: $0.24 | +12.5% | $209.8MEst: $201.5M | +4.2% | |
| Feb 27, 2025 | Q4 2024 | $0.24Est: $0.24 | 0.0% | $188.9MEst: $185.8M | +1.6% | |
| Nov 6, 2024 | Q3 2024 | $0.26Est: $0.23 | +13.0% | $180.7MEst: $174.5M | +3.5% | |
| Aug 6, 2024 | Q2 2024 | $0.24Est: $0.21 | +14.3% | $168.7MEst: $156.8M | +7.7% | |
| May 6, 2024 | Q1 2024 | $0.20Est: $0.17 | +17.6% | $156.9MEst: $146.2M | +7.3% | |
| Feb 28, 2024 | Q4 2023 | $0.22Est: $0.22 | 0.0% | $146.0MEst: $136.4M | +7.0% | |
| Nov 7, 2023 | Q3 2023 | $0.20Est: $0.19 | +5.3% | $140.2MEst: $130.6M | +7.4% | — |
| Aug 8, 2023 | Q2 2023 | $0.18Est: $0.16 | +12.5% | $132.3MEst: $126.7M | +4.4% | |
| May 4, 2023 | Q1 2023 | $0.13Est: $0.14 | -7.1% | $126.5MEst: $122.3M | +3.4% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.